The purpose of this study is to determine whether cysteamine bitartrate, an FDA-approved drug
for a non-psychiatric condition, is safe and effective for the treatment of major depression.
Phase:
N/A
Details
Lead Sponsor:
Icahn School of Medicine at Mount Sinai Murrough, James, M.D.